PGI Rohtak to start phase-2 trial of Bharat Biotech’s COVID-19 vaccine

Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech`s COVID-19 vaccine.Dr OP Kalra, Vice-Chancellor, PGI Rohtak said, “We got permission from Bharat Biotech to start a phase-2 human clinical trial of their vaccine. We`ve 300 volunteers, aged between 12 years and 65- years, out of which screening of 15 has been completed.”

“We hope to get vaccine dosages by tomorrow morning,” added Kalra.Recently, Niti Aayog member Dr Vinod K Paul said that Bharat Biotech`s vaccine candidate based on inactivated virus procured by ICMR and Zydus Cadila`s candidate based on viral DNA are two Indian COVID-19 vaccines in second phase trial.

“In India, Bharat Biotech`s vaccine candidate based on inactivated virus procured by ICMR is in the Phase II trial along with Zydus Cadila`s candidate which is based on viral DNA. The Oxford vaccine candidate developed by Serum Institute of India is already in Phase III trial in Maharashtra and some other States,” he said.

The total coronavirus cases in the country reached 42,04,614 including 8,82,542 active cases, 32,50,429 cured/ discharged/migrated and 71,642 deaths, as per the data from the Ministry of Health and Family  Welfare.

Editor JK News Updates

Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Three terror associates arrested in Jammu and Kashmir's Bandipora district

Tue Sep 8 , 2020
In a major success for security forces, Bandipora Police arrested three terror associates (OGWs) and recovered incriminating materials in Hajin area of Bandipora district of Jammu and Kashmir on Tuesday (September 8). Sources told Zee Media that Hajin police station recieved information from reliable sources that some miscreants at the […]

Breaking News

%d bloggers like this: